The diagnostic value of markers such as EMA, cytokeratins, CD10, RCC protein, PAX-2, or PAX-8, which are positive in CCRCC and negative in HBL, may be limited by the possibility of negative metastatic CCRCC cases [43, 47, 49]. This evidence concerns the gene LGALS1 and nonpapillary renal cell carcinoma.